Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
Compounds of the formula: wherein R1 and R2 are each selected from the group consisting of C1-C2 lower alkyl; X is NH or S; and n is a whole number within the range of 1-4 inclusive; and when n=0, X is (CH2)3 and the pharmaceutically acceptable salts thereof have been shown to be effective in treati...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
28.10.1997
|
Edition | 6 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Compounds of the formula: wherein R1 and R2 are each selected from the group consisting of C1-C2 lower alkyl; X is NH or S; and n is a whole number within the range of 1-4 inclusive; and when n=0, X is (CH2)3 and the pharmaceutically acceptable salts thereof have been shown to be effective in treating tamoxifen resistant tumors.
Compounds of the formula: wherein R1 and R2 are each selected from the group consisting of C1-C2 lower alkyl; X is NH or S; and n is a whole number within the range of 1-4 inclusive; and when n=0, X is (CH2)3 and the pharmaceutically acceptable salts thereof have been shown to be effective in treating tamoxifen resistant tumors. |
---|---|
AbstractList | Compounds of the formula: wherein R1 and R2 are each selected from the group consisting of C1-C2 lower alkyl; X is NH or S; and n is a whole number within the range of 1-4 inclusive; and when n=0, X is (CH2)3 and the pharmaceutically acceptable salts thereof have been shown to be effective in treating tamoxifen resistant tumors.
Compounds of the formula: wherein R1 and R2 are each selected from the group consisting of C1-C2 lower alkyl; X is NH or S; and n is a whole number within the range of 1-4 inclusive; and when n=0, X is (CH2)3 and the pharmaceutically acceptable salts thereof have been shown to be effective in treating tamoxifen resistant tumors. |
Author | BITONTI; ALAN J BAUMANN; RUSSELL J |
Author_xml | – fullname: BAUMANN; RUSSELL J – fullname: BITONTI; ALAN J |
BookMark | eNqFjLsKwkAQAK_Qwtc3uD-QQoIhrYhiJYJah03Y04O73eN2BfHrTWFvNTAMM3cTFqaZu5yFq0SGvcTwwT4SDFFSyE9iAmSM8lDwUsAKoSViA_FgmOQdPHFVSIMajtpeSYou3dRjVFr9uHDr4-G2P1WUpSPNOIxj6-7XbdNu2qbe1f-LL1v8OXQ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 6 |
ExternalDocumentID | US5681863A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US5681863A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:25:17 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US5681863A3 |
Notes | Application Number: US19940350192 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19971028&DB=EPODOC&CC=US&NR=5681863A |
ParticipantIDs | epo_espacenet_US5681863A |
PublicationCentury | 1900 |
PublicationDate | 19971028 |
PublicationDateYYYYMMDD | 1997-10-28 |
PublicationDate_xml | – month: 10 year: 1997 text: 19971028 day: 28 |
PublicationDecade | 1990 |
PublicationYear | 1997 |
RelatedCompanies | MERRELL PHARMACEUTICALS INC |
RelatedCompanies_xml | – name: MERRELL PHARMACEUTICALS INC |
Score | 2.4802952 |
Snippet | Compounds of the formula: wherein R1 and R2 are each selected from the group consisting of C1-C2 lower alkyl; X is NH or S; and n is a whole number within the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19971028&DB=EPODOC&locale=&CC=US&NR=5681863A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1bS8MwFD7MKeqbTmXe8yB9K8529vJQxLUbQ9gFt8neJLfiYE3G2qE_39OwTV_2FhI4JIFzzXe-ADxQxwtow03tkIW-3eTCs2nDobZwJfco9VxpSFx7fa87ab5Nn6cV-Nr0whie0G9DjogaxVHfC2OvF39FrMRgK_NHNsMp_dIZR4kl1u1ixl9aSStqDwfJILbiOJqMrP57VPJsBZ77ugf7GET7Jfir_dEqe1IW_x1K5wQOhihLFadQkaoGR_Hm37UaHPbWz904XGtefgbDvlZ2hnti2gCx5pLwuc5mJURLEqrKGkxOMAIlW-g40SkpaKZ_ZqlUNqbVZaiI08Uq08v8HO477XHctXFrn9tb-JyMNmdwL6CqtJJ1IC7nTyJMA4djdimYQGsVMiFY2qS-aPjyEuq7pFztXrqGY8PSiibaCW6gWixX8hZ9b8HuzLX9ArSTjbU |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf9MHsbRE3HNvDYmSDoMIgAoY30rVdIGErYSP653trAH3hrbkml2uT--zdrwAP1LBsWjMj3Qmdhl5n3NJpzaA6NwWzKLVMoUBce4HVGdffJ8-TAsy2szAKJ_RbgSOiRjHU90zZ6-VfEctXvZXpYzhHknxpj1xf45txMeUvNb_ptgZ9v-9pnueOh1rw6eY4W7Zlvh7AIQbYdo6y3_pq5jMpy_8OpX0KRwPklWRnUBBJGUre9t-1Mhz3Ns_duNxoXnoOg0AmeowyhVI1Yi0EYQsZz_MWLUFoktdgUoIRKNm1jhMZkYzG8mceiUTHtDoPFZGcrWO5Si-g2m6NvI6Ook13tzAdD7dnMC-hmMhEVICYjD1xJ7INhtklDzlaKyfkPIzqtMFrDXEFlX1crvdvVaHUGfW60-5b8HEDJwqxFc21Yd9CMVutxR364Sy8V1f4C4EckKU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Non-metabolizable+clomiphene+analogs+for+treatment+of+tamoxifen-resistant+tumors&rft.inventor=BAUMANN%3B+RUSSELL+J&rft.inventor=BITONTI%3B+ALAN+J&rft.date=1997-10-28&rft.externalDBID=A&rft.externalDocID=US5681863A |